Skip to main content


Exciting and important news in the diabetes sphere from the biggest diabetes conferences around the world. 

What’s next for getting this software to patients?
(S)he said what?!
DiabetesMine’s Innovation Summit shares updates on device connectivity, stigma research, the Bionic Pancreas, and more!
Twitter summary: #DBminesummit brings together top minds to discuss innovations in #diabetes – top 6 highlights below, full report coming soon! This past week, our team...
Will Medicare cover CGM? Will the FDA regulate meters? Experts meet in D.C. to discuss...
Twitter summary: dT presents at @US_FDA on interim results for CVOT trials in #diabetes & why we can’t delay innovation In 2008, the FDA mandated that companies...
Even diabetes experts find management challenging. How to go online and to your providers for support.
Expert Dr. Irl Hirsch’s eight tips for managing diabetes on a budget.
On September 27, Taking Control of Your Diabetes (TCOYD) will host its 6 th annual patient conference in Des Moines, Iowa. Founder Steve Edelman and his team have...
What can you do right now to advance diabetes advocacy? A summary from an insightful day at Masterlab.
Advances in type 1 diabetes at The American Diabetes Association 74th Scientific Sessions
Advances for type 2 diabetes at The American Diabetes Association 74th Scientific Sessions
This year at ADA, the science was exciting as always, but what really made us happy was the deep focus on patient perspectives.
What do Michelle Obama, soda, and cities have in common? Our top five patient takeaways from PHA this year.
A game-changing therapy for type 2 diabetes? Plus, the latest on predictive low glucose suspend, faster insulin, and a better Bydureon.
The FDA impresses us at The Diabetes Mine Innovation Summit. Plus, sleek new software for downloading data to the cloud.
Can more type 2 therapies be used for type 1 diabetes?
A whole new approach to treating type 2 diabetes at diagnosis, a new type of metformin, and the benefit of adding a GLP-1 agonist to insulin.
At ADA this year, type 2 drugs for type 1 diabetes show lots of promise. Plus, the latest exciting data on the Medtronic Veo and hypoglycemia.
What it felt like to forget about diabetes for a week.